Thrombocytémie essentielle révélée par un blue toe syndrome . Attention : la numération plaquettaire peut être normale

2018 ◽  
Vol 39 ◽  
pp. A184-A185
Author(s):  
Y. Cerveaux ◽  
V. Salle ◽  
A. Smail ◽  
P. Duhaut ◽  
J. Schmidt
Keyword(s):  
Blue Toe Syndrome

A Case of Blue Toe Syndrome with Livedo on Widespread Lesions.

1997 ◽  
Vol 59 (5) ◽  
pp. 675-677
Author(s):  
Hiroyoshi HANAKAWA ◽  
Norio OHTSUKI ◽  
Hiroyuki FUJII ◽  
Ryozou TATAMI ◽  
Shoichirou DAIMON
Keyword(s):  
Blue Toe Syndrome

Blue Toe Syndrome—Reply

2014 ◽  
Vol 132 (5) ◽  
pp. 654
Author(s):  
Ahmet Sarici ◽  
Osman Kizilkilic ◽  
Tiraje Celkan
Keyword(s):  
Blue Toe Syndrome

scholarly journals Massive Bone Marrow Necrosis with Polyclonal Hypergammaglobulinemia and Blue Toe Syndrome

Hematology ◽  
2000 ◽  
Vol 5 (2) ◽  
pp. 163-165 ◽  
Author(s):  
Tohru Murayama ◽  
Yoshitake Hayashi ◽  
Shion Imoto ◽  
Manabu Shimoyama ◽  
Hiroshi Matsuoka ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Necrosis ◽  
Polyclonal Hypergammaglobulinemia ◽  
Blue Toe Syndrome ◽  
Massive Bone

Durvalumab-associated vasculitis presenting as ‘the blue toe syndrome’

2020 ◽  
Vol 13 (11) ◽  
pp. e235886
Author(s):  
Shivangi Gupta ◽  
Dan Xu ◽  
Jane Hadfield ◽  
David Prentice
Keyword(s):  
Clinical Success ◽  
Survival Rates ◽  
Progression Free Survival ◽  
Small Cell ◽  
Check Point ◽  
Small Cell Lung ◽  
Livedo Racemosa ◽  
Free Survival ◽  
Check Point Inhibitors ◽  
Blue Toe Syndrome

Durvalumab is a selective, high-affinity human immunoglobulin monoclonal antibody in a class called check point inhibitors, that blocks PD-L1 on tumour cells. Despite clinical success in increasing progression-free survival rates in patients with stage III non-small-cell lung cancer, durvalumab has been associated with immune-related side effects such as pneumonitis and colitis. We present a case of an 84-year-old woman with acral vasculitis presenting as blue toe syndrome, associated with prolonged use of durvalumab. After 1 year of fortnightly durvalumab therapy postchemoradiation therapy, the patient came in with a left blue big toe, and later developed bilateral livedo racemosa. The diagnosis of durvalumab-associated vasculitis was made and treatment with prednisolone was started with clinical improvement.

scholarly journals Blue toe syndrome treated with sympathectomy in a patient with acute renal failure caused by cholesterol embolization

2013 ◽  
Vol 32 (4) ◽  
pp. 186-189 ◽  
Author(s):  
Min-Gang Kim ◽  
Soo Jin Kim ◽  
Jieun Oh ◽  
Sung Gyun Kim ◽  
Eun Suck Nam ◽  
...  
Keyword(s):  
Renal Failure ◽  
Acute Renal Failure ◽  
Blue Toe Syndrome

scholarly journals Blue toe syndrome, ischemic pain treated with digital block

2015 ◽  
Vol 10 (5) ◽  
pp. 637-638 ◽  
Author(s):  
Justin Belsky ◽  
Heidi Alvey ◽  
Alexis Bencze ◽  
Brooke Thompson ◽  
Stephanie Stokes-Buzzelli
Keyword(s):  
Ischemic Pain ◽  
Blue Toe Syndrome ◽  
Digital Block
Sign in / Sign up

Export Citation Format

Share Document